Pharma News

Merck and Pfizer have revealed that a Phase III trial assessing avelumab in patients with gastric cancer after two prior therapeutic regimens failed to hit its primary target of showing an improvement...

(Reuters) - ViiV Healthcare, GlaxoSmithKline Plc’s HIV unit, said on Thursday it started an African study to evaluate long-acting injectable drug for the prevention of HIV infection in sexua...

(Reuters Health) - Nearly three in five children in the U.

 Geneva - An estimated 1 in 10 medical products circulating in low- and middle-income countries is either substandard or falsified, according to new research from WHO.

The UK Medicines and Healthcare products Regulatory Agency (MHRA) has today announced Viagra Connect (containing sildenafil 5mg) will be formally classified from a prescription-only me...

American lawmakers meeting in a closed-door session reportedly received assurances from President Trump that he would be willing to support measures that would bolster the wobbling Obamacare exchange ...

Mumbai.

ViiV Healthcare has kicked off a late-stage study testing a long-acting, two-drug regimen of its cabotegravir and Janssen’s rilpivirine in virally suppressed adults with HIV-1 infection.

A new disease awareness campaign shines a light on the hallucinations and delusions that can affect half of people who have Parkinson’s disease.

LONDON (Reuters) - Drugmaker AstraZeneca plans to turbo-charge its already substantial Chinese business through a new drug development joint venture with a state-backed private equity fund.

New Teva CEO Kåre Schultz is getting down to business—and quickly.

It turns out that the quarter-crushing $575 million that drug wholesaler AmerisourceBergen set aside to settle civil litigation with the Justice Department was not enough.